Kerstin Cederlund
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kerstin Cederlund has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Johan Grunewald
Respiratory Medicine Division, Department of Medicine Solna, and Center for Molecular Medicine (CMM), Karolinska Institutet; and Respiratory Medicine, Theme Inflammation and Infection, Karolinska University Hospital, Stockholm, Sweden.
2 shared publications - Pernilla Darlington
Department of Internal Medicine, Södersjukhuset, Stockholm, Sweden; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden
2 shared publications - Anders Eklund
Department of Medicine and CMM, Respiratory Medicine Unit, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden
1 shared publication - Anders Eklund
Respiratory Medicine Unit, Department of Medicine Solna & Centre for Molecular Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden
1 shared publication - Anders Gabrielsen
Department of Medicine, Unit of Cardiology, Karolinska University Hospital, Stockholm, Sweden
1 shared publication - Boel Brynedal
Department of Clinical Neuroscience, Division of Neurology, Karolinska University Hospital Solna, Sweden
1 shared publication
Latest Publications
- Open Access
- 1 January 2014
- Published by Springer Nature in Respiratory Research
- Vol. 15 (1) , 15
Cardiac involvement in Caucasian patients with pulmonary sarcoidosis
Cardiac sarcoidosis (CS) is a potentially life-threatening condition. At present, there is no consensus with regard to the optimal non-invasive clinical evaluation and diagnostic procedures of cardiac involvement in patients with sarcoidosis. The aim of this study in a large homogenous Scandinavian sarcoidosis cohort was therefore to identify risk factors of cardiac involvement in patients with sarcoidosis, and the value of initial routine investigation with ECG and cardiac related symptoms in screening for CS.
- 1 January 2014
- Published by Springer Nature in Respiratory Research
- Vol. 15 (1) , 15
Open AccessCardiac involvement in Caucasian patients with pulmonary sarcoidosis
Cardiac sarcoidosis (CS) is a potentially life-threatening condition. At present, there is no consensus with regard to the optimal non-invasive clinical evaluation and diagnostic procedures of cardiac involvement in patients with sarcoidosis. The aim of this study in a large homogenous Scandinavian sarcoidosis cohort was therefore to identify risk factors of cardiac involvement in patients with sarcoidosis, and the value of initial routine investigation with ECG and cardiac related symptoms in screening for CS.
- Open Access
- 26 February 2010
- Published by Springer Nature in Respiratory Research
- Vol. 11 (1) , 25
Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients
A strong genetic influence by the MHC class II region has been reported in sarcoidosis, however in many studies with different results. This may possibly be caused by actual differences between distinct ethnic groups, too small sample sizes, or because of lack of accurate clinical subgrouping.
- 26 February 2010
- Published by Springer Nature in Respiratory Research
- Vol. 11 (1) , 25
Open AccessDifferent HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients
A strong genetic influence by the MHC class II region has been reported in sarcoidosis, however in many studies with different results. This may possibly be caused by actual differences between distinct ethnic groups, too small sample sizes, or because of lack of accurate clinical subgrouping.
- Open Access
- 4 June 2008
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 6 (1) , 26
Assessment of left ventricular volumes using simplified 3-D echocardiography and computed tomography – a phantom and clinical study
To compare the accuracy of simplified 3-dimensional (3-D) echocardiography vs. multi-slice computed tomography (MSCT) software for the quantification of left ventricular (LV) volumes. Three-D echocardiography (3-planes approach) and MSCT-CardIQ software were calibrated by measuring known volumes of 10 phantoms designed to closely mimic blood-endocardium interface. Subsequently, LV volumes were measured with both the methods in 9 patients referred routinely for coronary angiography and the agreement between the measurements was evaluated. Simplified 3D-echocardiography provided higher degree of agreement between the measured and true phantom volumes (mean difference 0 +/- 1 ml, variation range +4 to -4 ml) than MSCT software (mean difference 6 +/- 5 ml; variation range +22 to -10 ml). The agreement between LV measurements in the patients was considerably poorer, with significantly larger volumes produced by MSCT (mean difference -23 +/- 40 ml, variation between +93 and -138 ml). Simplified 3-D echocardiography provides more accurate assessment of phantom volumes than MSCT-CardIQ software. The discrepancy between the results of LV measurements with the two methods is even greater and does not warrant their interchangeable diagnostic use.
- 4 June 2008
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 6 (1) , 26
Open AccessAssessment of left ventricular volumes using simplified 3-D echocardiography and computed tomography – a phantom and clinical study
To compare the accuracy of simplified 3-dimensional (3-D) echocardiography vs. multi-slice computed tomography (MSCT) software for the quantification of left ventricular (LV) volumes. Three-D echocardiography (3-planes approach) and MSCT-CardIQ software were calibrated by measuring known volumes of 10 phantoms designed to closely mimic blood-endocardium interface. Subsequently, LV volumes were measured with both the methods in 9 patients referred routinely for coronary angiography and the agreement between the measurements was evaluated. Simplified 3D-echocardiography provided higher degree of agreement between the measured and true phantom volumes (mean difference 0 +/- 1 ml, variation range +4 to -4 ml) than MSCT software (mean difference 6 +/- 5 ml; variation range +22 to -10 ml). The agreement between LV measurements in the patients was considerably poorer, with significantly larger volumes produced by MSCT (mean difference -23 +/- 40 ml, variation between +93 and -138 ml). Simplified 3-D echocardiography provides more accurate assessment of phantom volumes than MSCT-CardIQ software. The discrepancy between the results of LV measurements with the two methods is even greater and does not warrant their interchangeable diagnostic use.